Clinical Updates | Conference Update Resource List
Did you miss EASL or AASLD 2016? Click HERE to learn about key clinical updates in Hepatitis C presented at recent conferences.
Last Updated on May 17, 2020 by HepFree NYC
Tags: HepCX NewsRelated Articles
-
Hepatitis A, B and C in New York City: 2023 Annual Report
The Hepatitis A, B and C in NYC: 2023 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
-
Congressional Hepatitis Caucus recognizes World Hepatitis Day 2012
The Congressional Hepatitis Caucus is a bi-partisan effort to build awareness, promote early treatment, advocate preventative measures, and push towards a cure for Hepatitis.
-
Request for Sites to Field Test CDC Hep C Counseling & Testing Manual
Battelle Centers for Public Health Research and Evaluation are working with the Centers for Disease Control and Prevention (CDC) to conduct a field assessment of a comprehensive counseling and testing manual for Hepatitis C (HCV).
-
Report | Hep B Birth Dose Coverage by NYC Facility (NYC Dept of Health, 2015)
Hep Free NYC supports the Immunization Action Coalition's National Hep B Birth Dose Honor Roll initiative. NYC Hep B Universal Birth Dose Initiative aims to gather support for the hepatitis B birth dose in New York City.
-
US Congress Eases Funding Restrictions for Syringe Access Programs
The US Senate and House of Representatives has eased restrictions on federal funding for elements of syringe access programs
-
NYS Attorney General to Investigate Insurers Over Hep C Drug Coverage
The NYS attorney general has asked 16 health insurance companies for information on their coverage of Hepatitis C treatments, amid concerns that some companies are restricting coverage of the medications.
-
Action Alert! Save Local Specialty Pharmacy
Tens of thousands of New York’s most vulnerable patients enrolled in Medicaid managed care plans are being forced to use mail order pharmacies to fill their HCV specialty prescriptions. This policy is detrimental to the long term medical outcome for chronically ill marginaliz...
-
Report | Eliminating Hep B and C in the US
The CDC and HHS Report states that Hep B and C could both be eliminated as public health problems in the U.S. but would take considerable will and resources.
